Skip to content

Effectiveness of Clonidine for the treatment of sciatica: A randomized, double-blind and prospective study. (EFFOC study)

Effectiveness of Clonidine for the treatment of radicular pain: A randomized, double-blind and prospective study. (EFFOC study) - EFFOC

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-003560-74-NL
Enrollment
Unknown
Registered
2012-09-18
Start date
2012-09-25
Completion date
Unknown
Last updated
2012-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radicular lumbar pain

Interventions

Trade Name: Catapresan Product Name: Clonidine Product Code: RVG 06055 Pharmaceutical Form: Injection

Sponsors

Leiden University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with lumbar radicular pain and NRS > 4 for longer than 6 weeks MRI evidence of a herniated disc Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 20 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 20

Exclusion criteria

Exclusion criteria: Obesity (BMI > 40) Coagulopathy Use of anticoagulation Systemic or local infection Allergy to local anesthetics, clonidine or steroids Legal claims or workman’s compensation Pregnancy FBSS Transforaminal epidural steroid injections or (pulsed) radiofrequency treatment at lumbar nerve roots within one year before inclusion in the study

Design outcomes

Primary

MeasureTime frame
Main Objective: 1) To study the effect of Clonidine on lumbar radicular pain with a transforaminal epidural injection after 1 week, 1, 3 and 6 months using a BPI.;Secondary Objective: 2) To study the effect of Clonidine on lumbar radicular pain with a transforaminal epidural injection after 1 week, 1, 3 and 6 months using the Ostwestry index;Primary end point(s): 1. Brief Pain Inventory (BPI) 2. Ostwestry Disability Questionnaire ;Timepoint(s) of evaluation of this end point: 1 hour post-intervention 1 week post-intervention 1 month post-intervention 3 months post-intervention 6 months post-intervention

Secondary

MeasureTime frame
Secondary end point(s): Ostwestry Index;Timepoint(s) of evaluation of this end point: 1 hour post-intervention 1 week post-intervention 1 month post-intervention 3 moonths post-intervention 6 months post-intervention

Countries

Netherlands

Contacts

Public ContactPain Center

Pain Center Leiden University Medical Center

c.boef@lumc.nl0031715262369

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026